Startups
Miltenyi Biomedicine GmbH develops innovative cell and gene therapies. We are focused on bringing cancer treatments and regenerative therapies to patients.
Overview
Location
Germany, North Rhine-Westphalia, Bergisch Gladbach
Employees
51-200
Founded date
2019
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 19, 2023 | Who are Nordrhein-Westfalen’s Top Health Care Innovators Changing the Industry? | Welcome to our revelatory piece dedicated to shining a light on a collective of astounding Health Care startups hailing from the quintessential region of Nordrhein-Westfalen, Germany. A sector that continues to grow in profound magnitude, t... |
| Jun 20, 2023 | Biotech Breakthroughs: Unraveling Germany’s 15 Emerging Biotechnology Startups | Emergence Therapeutics led by Jack Elands, is a promising biopharmaceutical company dedicated to advancing novel ADC immunotherapies to address cancers with high unmet needs. Table of Contents show 1 FaCellitate – Supporting Drug Discover... |
Reviews 0
FAQ about Miltenyi Biomedicine
When was Miltenyi Biomedicine founded?
Miltenyi Biomedicine was founded in 2019.
What has the press written about Miltenyi Biomedicine?
Parsers VC has collected 3 articles mentioning Miltenyi Biomedicine, among them “Who are Nordrhein-Westfalen’s Top Health Care Innovators Changing the Industry?” (Sep 19, 2023) and “Biotech Breakthroughs: Unraveling Germany’s 15 Emerging Biotechnology Startups” (Jun 20, 2023).
Is Miltenyi Biomedicine still active?
Yes, Miltenyi Biomedicine is active; its latest activity on Parsers VC dates from Jan 24, 2024.